Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PremaBiom
NCT07411261Not yet recruiting
- Sponsor
- CHU Caen Normandie
- Start
- Mar 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU Caen Normandie. Primary endpoint: Diagnosis of bronchopulmonary dysplasia. Planned start Mar 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07411261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07411261.